Progressive linear blaschkoid lupus erythematosus
Click on the article title to read more.
Related Articles
Discriminating Disease Flare From Infection in Febrile Patients With Systemic Lupus Erythematosus in a Safety‐Net Hospital System: A Multicenter Study
Objective The objective of this study was to assess clinical laboratory parameters that distinguish between disease flare and infection in febrile patients with systemic lupus…
Rheumatoid arthritis and risk of thyroid cancer: A nationwide cohort study
Objective Despite extensive cancer-related research in patients with rheumatoid arthritis (RA), there remains a paucity of studies on thyroid cancer in RA patients. We investigated…
A randomized, double‐blind, placebo‐controlled trial of abatacept for the treatment of relapsing, non‐severe, granulomatosis with polyangiitis
Objective To compare the efficacy of abatacept to placebo for the treatment of relapsing, non-severe granulomatosis with polyangiitis (GPA). Methods In this multicenter trial, eligible…
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation (GO‐GUT), an Early Remission Induction Study
Objective To evaluate the efficacy of tight-control, rapid escalation to TNF inhibition in early axial spondyloarthritis (axSpA) in relation to gut inflammation. Methods GO-GUT (NCT03270501)…
Loss of TRIM21 drives UVB‐induced systemic inflammation by regulating DNA‐sensing pathways
Background Patients with systemic lupus erythematosus (SLE) experience photosensitivity, with exposure to ultraviolet light B (UVB) driving lupus flares and triggering symptoms like joint pain, fati…
Muscle Vasculitis: A Novel Delineation of Distinct Subsets of Disease
Objective The objective of this study was to assess the clinical and histopathologic features of muscle vasculitis. Methods The electronic database of SA Pathology, wherein…
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients with Active Ankylosing Spondylitis: Results from an Adaptive Seamless Phase II/III Trial
Objective This randomized, double-blind, adaptive phase II/III trial aimed to evaluate the efficacy and safety of ivarmacitinib, a novel selective JAK1 inhibitor, in patients with…
Predicting the Impact of Air Quality Index on Rheumatoid Arthritis Disease Activity
Aim and objective This study explored the relationship between air pollution and rheumatoid arthritis (RA), focusing on how specific air quality components affect RA disease…
Editorial: The environment and Systemic Autoimmune Rheumatic Diseases (SARDS): What do we know after more than 15 years of research?
Click on the article title to read more.